Latest News of PBYI
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?
By Yahoo! Finance |
1 month ago
Return on Equity (ROE) measures a company's profit generation from shareholder investments. Puma Biotechnology's ROE of 18% is respectable, but its high debt level raises risks. ROE is a key indicator...
Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago
By Yahoo! Finance |
2 months ago
Puma Biotechnology, Inc. (NASDAQ:PBYI) saw a 79% drop in share price over five years. Despite recent profitability, revenue decline raises concerns about long-term growth. Investors should analyze com...
Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report
By Yahoo! Finance |
3 months ago
Puma Biotechnology exceeded market expectations in its recent quarterly results, with revenues beating forecasts by 5.4%. Analysts anticipate a 43% increase in earnings per share for 2024, showing imp...